1 long-form article and 0 pre-market mentions covering $AZN from AskMelon Research.
AstraZeneca closed Q1 2026 with $15.29 billion in revenue, up 8% at constant currency and 13% as reported, with an oncology franchise that grew 16% to $6.8 billion and now supplies 44% of the top line…